Vimarsana
Biggest News Aggregation in the World

Page 9 - Registration Statements News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Registration Statements. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Registration Statements Today - Breaking & Trending Today

RedHill Biopharma : and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola - Form 6-K -December 20, 2023 at 08:58 am EST - Vimarsana News

RedHill Biopharma : and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola - Form 6-K -December 20, 2023 at 08:58 am EST

Published: December 20, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K ...

Source: marketscreener.com
Related Topics:
Macau GeneralUnited StatesCoted IvoireHong KongUnited KingdomTel AvivSouth AfricaIvory CoastDror Ben AsherJeffrey KugelmanReza FathiRedhill BiopharmaAdi FrishUs Department Of DefenseGilead Sciences IncUs Army EbolaCommission File NoGermany Heidelberg PharmaceuticalsExchange Commission OnCenters For DiseaseCompany Annual Report On FormProduct Development PipelineCorporate Business DevelopmentCompany Expanded Access ProgramNational Institutes Of Health
Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors - Vimarsana News

Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors

Published: December 20, 2023

Dr. Margolin brings 35 years of expertise in biotechnology, pharma, and venture capital Purple Biotech also announces the resignation of Mr. Fabien Sebille, who served as the Company’s Chief...

Source: marketscreener.com
Related Topics:
Lior FhimaGil EfronYael MargolinCompany ContactTel Aviv UniversityGamida Cell LtdCompany Board Of DirectorsDrug AdministrationExchange CommissionDenali VenturesPurple Biotech LtdBristol Myers SquibbWeitzman Institute Of ScienceRamot At Tel Aviv UniversityYale University School Of MedicineTeva PharmaceuticalsFabien SebilleChief BusinessPoint Biopharma GlobalWelltech VenturesTel AvivChief Executive OfficerGamida CellVice PresidentCum Laude
Kornit Digital : Request for Additional Extension of Share Repurchase Program - Form 6-K -December 20, 2023 at 04:09 pm EST - Vimarsana News

Kornit Digital : Request for Additional Extension of Share Repurchase Program - Form 6-K -December 20, 2023 at 04:09 pm EST

Published: December 20, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE...

Source: marketscreener.com
Related Topics:
United StatesRosh HaayinHa AfonLauri HanoverAdditional Extension Of Share Repurchase ProgramCommission File NumberPrincipal Executive OfficeIsraeli Companies LawSecurities ExchangeKornit Digital LtdCompanies LawFile NumberAdditional ExtensionShare RepurchaseKornit DigitalSecurities Exchange ActExchange ActForeign Private IssuerRegistration Statements
Seanergy Maritime : INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K - Form 6-K -December 14, 2023 at 06:08 am EST - Vimarsana News

Seanergy Maritime : INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K - Form 6-K -December 14, 2023 at 06:08 am EST

Published: December 14, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT...

Source: marketscreener.com
Related Topics:
Perifereia AttikisMarshall IslandsUnited StatesStamatios TsantanisSeanergy Maritime Holdings CorpContinental Stock Transfer Trust CompanySecurities ExchangeBylaws Of The CompanyPerson Or Group Becoming An AcquiringHigh CourtBylaws Of Seanergy Maritime Holdings CorpCompany Registration Statements On FormBoard Of Directors The Company OnCommission File NumberExchange Act Or SecuritiesFile NumberRestated BylawsSeanergy Maritime HoldingsFourth AmendedBusiness Corporations ActSecurities Exchange ActExchange ActSecurities ActRestated Shareholders Rights AgreementShareholders Rights Agreement
Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer Trial - Vimarsana News

Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer Trial

Published: December 14, 2023

This acceleration of recruitment is expected to result in earlier look at overall survival of patients REHOVOT, Israel, Dec. 14, 2023 --  Purple Biotech Ltd. , a clinical-stage company...

Source: marketscreener.com
Related Topics:
Gil EfronLior FhimaBristol Myers SquibbDrug AdministrationExchange CommissionPurple Biotech LtdCompany ContactPurple BiotechTumor Associated AntigenLooking StatementsSafe HarborPrivate Securities Litigation Reform ActAnnual ReportRegistration Statements